Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Vimta Labs Ltd    VIMTALABS   INE579C01029

VIMTA LABS LTD

(VIMTALABS)
My previous session
Most popular
End-of-day quote. End-of-day quote NATIONAL STOCK EXCHANGE OF INDIA - 03/20
194.65 INR   -1.32%
2018VIMTA LABS LTD : Ex-dividend day for final dividend
FA
2016VIMTA LABS LTD : Ex-dividend day for final dividend
FA
2015VIMTA LABS LTD : Ex-dividend day for final dividend
FA
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
03/14/2019 03/15/2019 03/18/2019 03/19/2019 03/20/2019 Date
198.25(c) 200.55(c) 196.6(c) 197.25(c) 194.65(c) Last
41 050 26 857 52 859 37 487 29 945 Volume
-2.89% +1.16% -1.97% +0.33% -1.32% Change
More quotes
Company
Vimta Labs Limited is engaged in the business of contract research and testing services. The Company provides services of testing and contract research in the fields of clinical and pre-clinical studies, clinical reference, analytical testing, advanced molecular biology and environmental studies.... 
More about the company
Latest news on VIMTA LABS LTD
2018VIMTA LABS : Trailing twelve month results - vimta labs limited
AQ
2018VIMTA LABS : Quarterly results - vimta labs limited
AQ
2018SHARE HOLDING PATTERN AND MARKET RE : - vimta labs limited
AQ
2018VIMTA LABS LTD : Ex-dividend day for final dividend
FA
2018VIMTA LABS : Trailing twelve month results - vimta labs limited
AQ
2018VIMTA LABS : Quarterly results - vimta labs limited
AQ
2018VIMTA LABS : Trailing twelve month results - vimta labs limited
AQ
2018VIMTA LABS : Quarterly results - vimta labs limited
AQ
2016VIMTA LABS LTD : Ex-dividend day for final dividend
FA
2015VIMTA LABS LTD : Ex-dividend day for final dividend
FA
More news
Sector news : Bio Diagnostics & Testing
03/11Regeneron Says FDA Approves Dupixent for Atopic Dermatitis in Adolescents
DJ
03/08Regeneron, Sanofi Get FDA Priority Review for Dupixent
DJ
03/07SHANGHAI RAAS BLOOD PRODUCTS : Spain's Grifols, China's Shanghai RAAS form strat..
RE
03/06GILEAD SCIENCES : Says Once-Daily HIV Regimen Shows Promise in Treating Teens an..
DJ
03/05FDA Approves Controversial Drug for Depression -- Update
DJ
More sector news : Bio Diagnostics & Testing
Chart VIMTA LABS LTD
Duration : Period :
Vimta Labs Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VIMTA LABS LTD
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Managers
NameTitle
Harita Vasireddi Managing Director & Executive Director
Sivalinga Prasad Vasireddi Non-Executive Chairman
Harriman Vungal Executive Director & Executive Director-Operations
Amit Pathak Chief Financial Officer
Sireesh Chandra Vungal Group Vice President-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
VIMTA LABS LTD-38.02%63
GUARDANT HEALTH INC126.27%7 560
GENSCRIPT BIOTECH CORP43.62%3 507
INVITAE CORP--.--%2 115
CAREDX INC55.97%1 544
MIRACA HOLDINGS INC.19.00%1 502